The effect of prophylaxis therapy on prevention from gastrointestinal bleeding in ICU in patients

SK Nezam; Shahram Borjian Boroojeny; Omid Rahati

Zahedan Journal of Research in Medical Sciences

The Official Journal of Zahedan University of Medical Sciences

Current Issue All Issues In Press Articles Accepted Manuscripts Search

Journal Information Boards and Committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Contact Us Support Reviewer and AE Registration Form

APC

Authors Guide Submit Manuscript

The effect of prophylaxis therapy on prevention from gastrointestinal bleeding in ICU in patients

Author(s):

SK Nezam^1,*,

Shahram Borjian Boroojeny²,

Omid Rahati²

1Internal Medicine Dept, Faculty of Medicine, Zahedan University of Medical Sciences and health services, Zahedan, Iran.

2Anesthesia and Intensive Care Dept, Faculty of Medicine, Zahedan University of Medical Sciences and health services, Zahedan, Iran.

Zahedan Journal of Research in Medical Sciences:Vol. 7, issue 3; e94935

Published online:Mar 06, 2005

Article type:Research Article

Received:Jan 04, 2003

Accepted:Feb 26, 2004

How to Cite:SK NezamShahram Borjian BoroojenyOmid RahatiThe effect of prophylaxis therapy on prevention from gastrointestinal bleeding in ICU in patients.Zahedan J Res Med Sci.7(3):e94935.

Abstract

Background: Stress ulcerations are the most common cause of gastrointestinal bleeding in
intensive care unit (ICU) patients, prophylaxis therapy may decrease mortality. However, the cost
and side effects pose restrictions to its use. In this study ICU in patients who received. Sucralfate
and Ranitidine were compared to a similar group who did not receive prophylaxis in terms of
gastrointestinal bleeding.
Methods and Materials: In this study (clinical trial) 150 in patients of ICU ward in Katam
(PBHH) were investigated from Mehr 1380 to Urdibehesht 1381. patients were divided into 3
groups of 50 at random the group I were given 1gm sucraflate every 6 hours, group II were given
50mg Ranitidine every 8 hours, control group received no drug.
In this study endpoint primary hemorrhage was due to stress ulcerations.
Results: There were 13 cases (26 %) of hemorrhage in sucralfate group, 6 cases (12%) in
Ranitidine, and 12 cases (24%) in control group. Stress-related hemorrhage in patients who
received sucralfate in comparison to those in control group (P=0.8174) and also in comparison to
ranitidine group did not have significant difference (P=0.7440). Hemoohage to stress ulcerations in
patients who received Ranitidine in comparison to those in control group did not have significant
difference (P=0.1184.)
Conclusions: this study revealed that gastrointestinal bleeding due to stress –ulcerations in
patients who received Sucralfate or Ranitidine in comparison to those who received no prophylaxis
therapy for stress ulcerations did not have significant difference which was in conformity with other
studies conducted previously.

Keywords

Stress-ulceration

Sucralfate

Ranitidine

Fulltext

The full text of this article is available on the PDF file.

References

1.
The References of this article are available on the PDF file.

comments